Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert R Henry

Showing results (61-70 of 155) with videos related to

Pageof 16
Sort By:
American Journal of Nephrology|May 21, 2018
Uromodulin mRNA from Urinary Extracellular Vesicles Correlate to Kidney Function Decline in Type 2 Diabetes MellitusCindy M Yamamoto, Taku Murakami, Melanie L Oakes, et al.
Fertility and Sterility|August 21, 2007
Circulating and cellular adiponectin in polycystic ovary syndrome: relationship to glucose tolerance and insulin actionVanita Aroda, Theodore P Ciaraldi, Sang-Ah Chang, et al.
Diabetes Care|October 27, 2004
Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetesJohn B Buse, Robert R Henry, Jenny Han, et al.
American Journal of Physiology. Endocrinology and Metabolism|February 25, 2005
Impaired fatty acid metabolism in type 2 diabetic skeletal muscle cells is reversed by PPARgamma agonistsBong-Soo Cha, Theodore P Ciaraldi, Kyong-Soo Park, et al.
American Journal of Physiology. Endocrinology and Metabolism|July 23, 2009
Selective regulation of cellular and secreted multimeric adiponectin by antidiabetic therapies in humansSusan A Phillips, Jacqueline Kung, Theodore P Ciaraldi, et al.
Endocrine|December 4, 2008
Myotoxic reactions to lipid-lowering therapy are associated with altered oxidation of fatty acidsPaul S Phillips, Theodore P Ciaraldi, Dong-Lim Kim, et al.
Annals of the New York Academy of Sciences|June 25, 2002
Free fatty acid metabolism in human skeletal muscle is regulated by PPARgamma and RXR agonistsTheodore P Ciaraldi, Bong-Soo Cha, Kyong-Soo Park, et al.
Diabetes Technology & Therapeutics|November 19, 2013
Changes in insulin sensitivity and insulin secretion with the sodium glucose cotransporter 2 inhibitor dapagliflozinSunder Mudaliar, Robert R Henry, Guenther Boden, et al.
Diabetes, Obesity & Metabolism|March 31, 2023
Astaxanthin, a natural antioxidant, lowers cholesterol and markers of cardiovascular risk in individuals with prediabetes and dyslipidaemiaTheodore P Ciaraldi, Schafer C Boeder, Sunder R Mudaliar, et al.
Clinical Therapeutics|May 22, 2012
Efficacy of GLP-1 receptor agonists and DPP-4 inhibitors: meta-analysis and systematic reviewVanita R Aroda, Robert R Henry, Jenny Han, et al.
Pageof 16

Showing results (61-70 of 155) with videos related to

Sort By:
Pageof 16
American Journal of Nephrology|May 21, 2018
Uromodulin mRNA from Urinary Extracellular Vesicles Correlate to Kidney Function Decline in Type 2 Diabetes MellitusCindy M Yamamoto, Taku Murakami, Melanie L Oakes, et al.
Fertility and Sterility|August 21, 2007
Circulating and cellular adiponectin in polycystic ovary syndrome: relationship to glucose tolerance and insulin actionVanita Aroda, Theodore P Ciaraldi, Sang-Ah Chang, et al.
Diabetes Care|October 27, 2004
Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetesJohn B Buse, Robert R Henry, Jenny Han, et al.
American Journal of Physiology. Endocrinology and Metabolism|February 25, 2005
Impaired fatty acid metabolism in type 2 diabetic skeletal muscle cells is reversed by PPARgamma agonistsBong-Soo Cha, Theodore P Ciaraldi, Kyong-Soo Park, et al.
American Journal of Physiology. Endocrinology and Metabolism|July 23, 2009
Selective regulation of cellular and secreted multimeric adiponectin by antidiabetic therapies in humansSusan A Phillips, Jacqueline Kung, Theodore P Ciaraldi, et al.
Endocrine|December 4, 2008
Myotoxic reactions to lipid-lowering therapy are associated with altered oxidation of fatty acidsPaul S Phillips, Theodore P Ciaraldi, Dong-Lim Kim, et al.
Annals of the New York Academy of Sciences|June 25, 2002
Free fatty acid metabolism in human skeletal muscle is regulated by PPARgamma and RXR agonistsTheodore P Ciaraldi, Bong-Soo Cha, Kyong-Soo Park, et al.
Diabetes Technology & Therapeutics|November 19, 2013
Changes in insulin sensitivity and insulin secretion with the sodium glucose cotransporter 2 inhibitor dapagliflozinSunder Mudaliar, Robert R Henry, Guenther Boden, et al.
Diabetes, Obesity & Metabolism|March 31, 2023
Astaxanthin, a natural antioxidant, lowers cholesterol and markers of cardiovascular risk in individuals with prediabetes and dyslipidaemiaTheodore P Ciaraldi, Schafer C Boeder, Sunder R Mudaliar, et al.
Clinical Therapeutics|May 22, 2012
Efficacy of GLP-1 receptor agonists and DPP-4 inhibitors: meta-analysis and systematic reviewVanita R Aroda, Robert R Henry, Jenny Han, et al.
Pageof 16